
Paroxewave 12.5mg Tablet CR
Marketer
Axonwave Pharmaceuticals Private Limited
Salt Composition
Paroxetine (12.5mg)
Overview Paroxewave 12.5mg Tablet CR
Sertraline CR 12.5mg tablets are antidepressants classified as selective serotonin reuptake inhibitors (SSRIs). Prescribed extensively for depression and anxiety disorders such as obsessive-compulsive disorder and panic attacks, these tablets help many individuals recover by alleviating symptoms of low mood, anxiety, and tension. Administration is independent of food intake; dosage and frequency are determined by your physician to effectively manage your symptoms. Your doctor might initiate treatment with a lower dose, gradually increasing it as needed. Never alter your dosage or discontinue use without consulting your doctor; abrupt cessation can worsen your condition or trigger withdrawal (including anxiety, agitation, rapid heartbeat, dizziness, sleep problems, etc.). For optimal results, take the medication consistently at the same time daily—morning administration may be recommended if sleep is affected. Significant improvement may take several weeks. Report any lack of progress after four weeks. Common side effects encompass nausea, tiredness, dry mouth, appetite changes, increased perspiration, lightheadedness, nervousness, shaking, sleep difficulties, and constipation. Reduced libido, delayed ejaculation, and impotence are also potential sexual side effects. Report immediately any sudden mood deterioration or suicidal thoughts. Prior to commencing treatment, inform your doctor of any epilepsy, diabetes, liver or kidney impairment, heart conditions, or glaucoma as these may influence treatment. Consult your physician before use if pregnant or breastfeeding. Interactions are possible with certain medications, particularly other antidepressants and MAO inhibitors; provide your doctor with a complete list of all your medications to ensure safety.
Uses of Paroxewave 12.5mg Tablet CR
Managing depressive symptoms | Addressing panic attacks and panic disorder | Anxiety disorder intervention and care
Major Benefits of Paroxewave 12.5mg Tablet CR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Paroxewave 12.5mg Controlled-Release tablet can be administered with or without food, although consistent timing is recommended.
Common Side effects of Paroxewave 12.5mg Tablet CR:
- Nausea
- Fatigue
- Dryness in mouth
- Loss of appetite
- Increased sweating
- Dizziness
- Nervousness
- Tremors
- Low sexual desire
- Insomnia (difficulty in sleeping)
- Confusion
- Constipation
- Erectile dysfunction
- Delayed ejaculation
- Decreased libido
How to use Paroxewave 12.5mg Tablet CR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Paroxewave 12.5mg Tablet CR whole; do not break, crush, or chew it. While you can take it with or without food, consistency is key—choose a specific time each day.
How Paroxewave 12.5mg Tablet CR works:
Serotonin levels in the brain are boosted by the extended-release Paroxewave 12.5mg tablet, a selective serotonin reuptake inhibitor (SSRI) used to treat depression. This mechanism alleviates depressive symptoms, both emotional and physical, and offers relief from panic disorder, anxiety, and obsessive-compulsive disorder.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Paroxewave 12.5mg Tablet CR is inadvisable.
PregnancyUNSAFE
The extended-release Paroxewave 12.5mg tablet is contraindicated in pregnancy. Preclinical and clinical studies reveal substantial risks to fetal development, mandating consultation with a physician before use during gestation.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Paroxetine 12.5mg tablets are likely unsuitable for breastfeeding mothers. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Extended-release Paroxewave 12.5mg tablets can reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with impaired kidney function should use Paroxewave 12.5mg controlled-release tablets cautiously. Dosage modification of Paroxewave 12.5mg controlled-release tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Paroxewave 12.5mg Controlled-Release tablets. Dosage modification of Paroxewave 12.5mg Controlled-Release tablets may be necessary. Physician consultation is advised.
What if you forget to take Paroxewave 12.5mg Tablet CR :
Should you forget to take a Paroxewave 12.5mg Controlled-Release tablet, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.
Facts to Know About Paroxewave 12.5mg Tablet CR
| Label | Value |
|---|---|
| Type of Compound | Piperidine-based phenyl derivative |
| Potential for Dependence | None. |
| Treatment Category | Central and Peripheral Nervous System |
| Mechanism of Action | Serotonin-specific reuptake inhibitors |
